17,881 resources
By Version
By Realm
Start Prev Rows 11400 - 11600 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.fhir.au.base | R4 | au-observation-category-extended | Observation Category Codes - AU Extended | trial-use | 0 | 2025-06 | au | fhir tho | |
hl7.terminology | R5 | observation-category | Observation Category Codes | active | 1 | oo | 2024-04 | uv | tho |
signal.core.r4 | R4 | observation-category | Observation Category Codes | draft | 1 | oo | 2019-10 | us | tho |
fhir.outburn.co.il | R4 | vs-observation-interpretation | Observation Interpretation | draft | us | tho | |||
ee.hl7.fhir.base.r5 | R5 | ee-observation-category | Observation Category | draft | 2023-08 | ee | tho | ||
ee.fhir.terminology | R5 | observation-category | Observation Category | active | 2025-06 | ee | tho | ||
ca.on.oh-olis | R4 | olis-ObservationCategoryCodes | ObservationCategoryCodes | active | tho | ||||
hl7.fhir.us.vdor | R4 | vdor-toxicology-summary-tests-vs | VDOR Toxicology Summary Tests Value Set | informative | pher | 2025-06 | us | fhir | |
hl7.terminology | R5 | v3-ObservationInterpretationExpectation | ObservationInterpretationExpectation | active | 2019-03 | uv | tho | ||
hl7.fhir.uv.pocd | R4 | observation-interpretation | Observation interpretation codes | draft | 2019-09 | uv | fhir tho | ||
hl7.terminology | R5 | v3-PopulationInclusionObservationType | PopulationInclusionObservationType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-CompositeMeasureScoring | CompositeMeasureScoring | active | cqi | 2019-03 | uv | tho | |
hl7.terminology | R5 | measure-improvement-notation | MeasureImprovementNotation | active | 2 | cqi | 2024-04 | uv | tho |
hl7.terminology | R5 | v3-ObservationPopulationInclusion | ObservationPopulationInclusion | retired | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue | active | 2010-03 | uv | sct rx tho ndc loinc | ||
hl7.terminology | R5 | v3-KnowledgeSubtopicObservationValue | KnowledgeSubtopicObservationValue | active | 2010-03 | uv | sct | ||
hl7.terminology | R5 | v3-SecurityObservationValue | SecurityObservationValue | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-AgeGroupObservationValue | AgeGroupObservationValue | active | 2010-03 | uv | |||
hl7.terminology | R5 | v3-ObservationMeasureType | ObservationMeasureType | active | 2014-08 | uv | tho | ||
uk.nhsdigital.r4.test | R4 | 8fbd7c75-858b-4932-87dc-a5e8d29e40c1 | ObservationCategory | draft | 2022-08 | tho | |||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-observations | Observations | draft | 2024-05 | uv | sct loinc | ||
hl7.fhir.us.breast-radiology | R4 | ObservedChangesVS | ObservedChanges ValueSet | active | 2022-12 | us | fhir | ||
hl7.fhir.cz.terminology | R5 | nrzp-povolani-vs | Occupation of healthcare practitioner (CZ) | trial-use | 2 | 2024-01 | cz | ||
hl7.eu.fhir.idea4rc | R4 | occurrence-other-cancer-i4rc | Occurrence of other cancer | active | 2025-07 | eu | |||
ca.on.oh.mha-pds | R4 | ValueSet.ca-on-mha-PreferredOfficialLanguage | Preferred Official Language | active | 2022-08 | ca | tho ietf | ||
hl7.fhir.be.pss | R4 | OncologyPatientCodes | OncologyPatient Codes | active | 2025-07 | be | sct icd icpc | ||
hl7.terminology | R5 | v3-CalendarCycleOneLetter | CalendarCycleOneLetter | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ObservationInterpretation | ObservationInterpretation | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-Sibling | Sibling | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xParticipationAuthorPerformer | x_ParticipationAuthorPerformer | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xParticipationVrfRespSprfWit | x_ParticipationVrfRespSprfWit | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationEscort | ParticipationEscort | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationWitness | ParticipationWitness | active | 2014-03 | uv | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20200901000000 | OntwikkelingMotoriekCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20171231000000 | OntwikkelingMotoriekCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20200901000000 | OntwikkelingSociaalCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20171231000000 | OntwikkelingSociaalCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20200901000000 | OntwikkelingTaalCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20171231000000 | OntwikkelingTaalCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20200901000000 | OntwikkelingVerstandelijkCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20171231000000 | OntwikkelingVerstandelijkCodelijst | active | nl | sct | |||
basisprofil.de | R3 | ValueSet-dimdi-ops | ops | draft | 2017-09 | ||||
hl7.terminology | R5 | v3-OphthalmicRoute | OphthalmicRoute | active | 2014-03 | uv | tho | ||
fhir.cdc.opioid-cds-r4 | R4 | synthetic-opioid-medications | Synthetic opioid medications | active | 2023-05 | us | |||
hl7.terminology | R5 | v3-OralRoute | OralRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.us.carin-bb | R4 | OralBodySite | Oral Body Site Value Set | trial-use | fm | 2025-02 | us | tho | |
hl7.terminology | R5 | v3-OtherActionTakenManagementCode | OtherActionTakenManagementCode | active | 2014-03 | uv | tho | ||
hl7.fhir.us.hai | R4 | nhsn-pathogen-ranking | NHSNPathogenRanking | active | 2023-09 | us | sct | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.17.2.3--20200901000000 | OrganisatieTypeCodelijst | active | nl | ||||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.17.2.3--20171231000000 | OrganisatieTypeCodelijst | active | nl | ||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1237.13 | SNOMED Organism from LOINC Answer List | active | 2024-01 | us | sct | ||
hl7.fhir.cr.core | R5 | expedition-organization-patient-identifier | Organización que expiden tipos de identificación para el paciente | draft | 0 | cgp | 2025-03 | cr | internal |
ForgePatientChart.0830 | R4 | telus-organizationaffiliation-partner | TELUS ValueSet - Organization Affiliation partner | draft | 2020-11 | ||||
ee.hl7.fhir.base.r5 | R5 | ee-organization-type | Organization Types | draft | 2023-08 | ee | tho | ||
ee.fhir.terminology | R5 | organization-type | Organization Types | active | 2025-06 | ee | tho | ||
hl7.fhir.fr.core | R4 | fr-core-vs-organization-uf-activity-field | FR Core ValueSet Organization UF activity field | informative | 1 | fhir | 2024-09 | fr | internal |
ca.on.ppr.r4 | R4 | OrganizationOperationalStatus-provider | OperationalStatus | draft | |||||
hl7.fhir.fr.core | R4 | fr-core-vs-organization-type | FR Core ValueSet Organization type | active | 2024-09 | fr | internal | ||
hl7.fhir.sami.core | R4 | Human_sex_orientation | Orientação sexual | active | 2022-02 | sami | |||
hl7.fhir.cl.minsal.nid | R4 | VSOrigenDiscapacidad | Origen Discapacidad | active | 2023-01 | cl | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1010.8 | Vaccine Clinical Drug | active | 2024-06 | us | rx | ||
hl7.terminology | R5 | v3-OromucosalRoute | OromucosalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-OropharyngealRoute | OropharyngealRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.be.pss | R4 | OtherCodes | Other Codes | active | 2025-07 | be | sct | ||
hl7.eu.fhir.pcsp | R4 | otherInfos-condition-vs | Other Infors Condition | draft | 2025-08 | eu | sct | ||
hl7.eu.fhir.idea4rc | R4 | other-treatment-procedure-type-eu-i4rc | Other Treatment Procedure Type | draft | 2025-07 | eu | |||
fhir.giis | R4 | OtherVaccineVS | Other Vaccine codes | draft | 2025-07 | us | internal | ||
hl7.fhir.nz.cca | R4 | sact-plan-definition-status-code | PlanDefinition additional status | active | 2020-11 | nz | |||
hl7.eu.fhir.pcsp | R4 | vs-othUnkTxt-eu-pcsp | Other/Unknown/Text | draft | 2025-08 | eu | tho | ||
hl7.terminology | R5 | v3-OticRoute | OticRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.cl.minsal.eis | R4 | VSOtroTipoEstabAsistenciales | OtroTipoEstabAsistenciales | active | 2023-01 | cl | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.86 | Pregnancy Outcome | active | 2024-06 | us | sct | ||
hl7.terminology | R5 | adverse-event-category | AdverseEventCategory | active | 0 | pc | 2024-04 | uv | tho |
hl7.terminology | R5 | adverse-event-seriousness | AdverseEventSeriousness | active | 1 | pc | 2024-04 | uv | tho |
hl7.org.nz.fhir.ig.formulary | R4B | nzf-funding-type | PHARMAC funding type | active | 2025-08 | nz | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.4436 | Gentamicin medications | active | 2024-05 | us | rx | ||
hl7.fhir.us.registry-protocols | R4 | PCIOperator | PCI Operator SNOMED codes | active | cic | 2023-11 | us | sct | |
hl7.eu.fhir.unicom | R5 | material-vs | EMA SPOR Material | draft | 2025-06 | eu | |||
hl7.eu.fhir.unicom | R5 | packaging-spor-vs | EMA SPOR Packaging | draft | 2025-06 | eu | |||
hl7.org.nz.fhir.ig.formulary | R4B | nzf-page-size | Nzf page size | active | 2025-08 | nz | |||
hl7.fhir.cl.minsal.eis | R4 | VSPaises | Paises | active | 2023-01 | cl | internal | ||
hl7.eu.fhir.pcsp | R4 | vs-radiotherapy-pcsp | Radiotherapy sites | draft | 2025-08 | eu | internal tho | ||
ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-paper-format | Paper Formats | draft | 2025-01 | ch | internal | ||
hl7.terminology | R5 | v3-ParanasalSinusesRoute | ParanasalSinusesRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParenteralRoute | ParenteralRoute | active | 2014-03 | uv | tho | ||
ca.on.oh-olis | R4 | olis-ParticipantType | ParticipantType | active | tho | ||||
ca.on.dhdr.r4.v4 | R4 | encounter-participant-type | Encounter Participant Type | active | 2019-02 | us | tho | ||
hl7.terminology | R5 | v3-ParticipationHolder | ParticipationHolder | active | 2014-03 | uv | tho | ||
openehr.base | R5 | participation-function | Participation Function | informative | 3 | fhir | 2024-08 | uv | |
openehr.base | R5 | participation-mode | Participation Mode | informative | 3 | fhir | 2024-08 | uv | |
hl7.terminology | R5 | v3-ParticipationModeWritten | ParticipationModeWritten | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationModeElectronicData | ParticipationModeElectronicData | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationModeVerbal | ParticipationModeVerbal | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationAncillary | ParticipationAncillary | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationInformationGenerator | ParticipationInformationGenerator | active | 2014-03 | uv | tho | ||
hl7.eu.fhir.idea4rc | R4 | pathologicalN-i4rc | Pathological N | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | pathologicalT-i4rc | Pathological T | active | 2025-07 | eu | |||
hl7.fhir.us.registry-protocols | R4 | PatientCenteredReasonforDelay | Patient Centered Reason for Delay | active | cic | 2023-11 | us | fhir | |
fhir.kenyaPSIG | R4 | PatientContactRlshipVS | Patient Contact Relationship ValueSet | draft | 2025-07 | us | internal | ||
hl7.fhir.us.davinci-pct | R4 | PCTTaskAttachmentContentType | PCT Task Attachment Mime Types | trial-use | fm | 2025-08 | us | ietf | |
hl7.fhir.fr.core | R4 | fr-core-vs-marital-status | FR Core ValueSet Patient gender INS ValueSet | active | 2024-09 | fr | internal tho | ||
hl7.fhir.fr.core | R4 | fr-core-vs-patient-gender-INS | FR Core ValueSet Patient gender INS ValueSet | active | 2024-09 | fr | fhir | ||
ca.on.oh-olis | R4 | PatientIdentifierType | PatientIdentifierType | active | tho | ||||
fhir.kenyaPSIG | R4 | PatientIdentifierTypesVS | Patient Identifier Types ValueSet | draft | 2025-07 | us | internal | ||
fhir.giis | R4 | AEFIPatientStatusVS | Patient Status related to an AEFI codes | draft | 2025-07 | us | internal | ||
hl7.terminology | R5 | v3-PatientImportance | PatientImportance | active | 2014-03 | uv | tho | ||
hl7.fhir.be.terminology | R4 | be-vs-patientwill-code | Patient Will code Value Set | active | 2020-10 | be | |||
ehealthplatform.be.r4.federalprofiles | R4 | be-vs-patientwill-code | Patient Will code Value Set | active | 2020-10 | internal | |||
hl7.fhir.be.terminology | R4 | be-vs-patientwill-scope | BeVSPatientWillScope | active | 2024-01 | be | sct | ||
ForgePatientChart.0830 | R4 | telus-identifier-system-patient-jhn | TELUS ValueSet - Identifier System Patient JHN | draft | 2021-03 | iso | |||
fhir.kenyaPSIG | R4 | PatientTitleVS | Patient title | draft | 2025-07 | us | internal | ||
hl7.fhir.be.terminology | R4 | be-vs-patientwill-category | Patient Will Category | active | 2020-10 | be | |||
ehealthplatform.be.r4.federalprofiles | R4 | be-vs-patientwill-category | Patient Will Category | active | 2020-10 | internal | |||
hl7.fhir.uv.ichom-breast-cancer | R4 | SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet | trial-use | 2 | 2023-08 | uv | sct tho | |
ch.fhir.ig.ch-term | R4 | DocumentEntry.sourcePatientInfo.PID-8 | DocumentEntry.sourcePatientInfo.PID-8 | active | 2025-05 | ch | fhir | ||
ch.fhir.ig.ch-epr-term | R4 | DocumentEntry.sourcePatientInfo.PID-8 | DocumentEntry.sourcePatientInfo.PID-8 | active | 2023-12 | ch | fhir | ||
hl7.fhir.ee.mpi | R5 | education-level | Education Level | draft | 2023-12 | ee | internal | ||
ee.fhir.terminology | R5 | omandatud-korgeim-haridus | Omandatud kõrgeim haridus | active | 2025-06 | ee | internal | ||
hl7.fhir.ee.mpi | R5 | legal-status | Legal Status | draft | 2023-12 | ee | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1045.66 | PCI | active | 2017-05 | us | cms | ||
hl7.fhir.us.military-service | R4 | military-service-paygrade-vs | Pay Grade Code Value Set | active | 2023-05 | us | fhir | ||
hl7.fhir.us.ndh | R4 | NdhDirectTrustPayloadTypeVS | NDH Direct Trust Payload Type Value Set | trial-use | pa | 2025-07 | us | fhir ihe tho | |
us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.80.18 | Medication Drug Class | active | 2024-06 | us | fhir | ||
hl7.terminology | R5 | v3-PerianalRoute | PerianalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PeriarticularRoute | PeriarticularRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PeriduralRoute | PeriduralRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PerinealRoute | PerinealRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PerineuralRoute | PerineuralRoute | active | 2014-03 | uv | tho | ||
ch.fhir.ig.ch-crl | R4 | nkrs-perineuralinvasion | NKRS - Perineural Invasion | active | 2022-02 | ch | internal | ||
hl7.terminology | R5 | v3-PeriodontalRoute | PeriodontalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActMoodResourceSlot | ActMoodResourceSlot | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PermanentDentition | PermanentDentition | active | 2014-03 | uv | tho | ||
hl7.fhir.cl.minsal.nid | R4 | VSClasesDeCobertura | Clase de Cobertura de Salud | active | 2023-01 | cl | internal | ||
ee.hl7.fhir.base.r5 | R5 | ee-person-relationship | Person Relationship | draft | 2023-08 | ee | sct | ||
hl7.fhir.ee.mpi | R5 | person-relationship-class | Person Relationship Class | draft | 2023-12 | ee | tho | ||
hl7.eu.fhir.unicom | R5 | pharmaceutical-doseform-vs | EMA SPOR Pharmaceutical Dose Form | draft | 2025-06 | eu | |||
hl7.fhir.us.davinci-drug-formulary | R4 | PharmacyBenefitTypeVS | Pharmacy benefit types | trial-use | phx | 2025-02 | us | fhir | |
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.9.3--20171231000000 | PijnLateraliteitCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.9.1--20200901000000 | PijnMeetmethodeCodelijst | active | nl | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.9.1--20171231000000 | PijnMeetmethodeCodelijst | active | nl | oid | |||
signal.core.r4 | R4 | questionnaire-ccars-place-of-residence | Questionnaire CCARS Place Of Residence | draft | 1 | pa | us | ||
hl7.fhir.us.vrdr | R4 | vrdr-place-of-injury-other-vs | Place of Injury - Other ValueSet | active | pher | 2024-10 | us | fhir | |
hl7.fhir.us.vrdr | R4 | vrdr-place-of-injury-vs | Place of Injury ValueSet | active | pher | 2024-10 | us | tho loinc | |
hl7.fhir.us.carin-bb | R4 | CMSPlaceofServiceCodes | CMS Place of Service Codes (POS) Value Set | trial-use | fm | 2025-02 | us | cms | |
hl7.fhir.us.mcode | R4 | tg263-vs | TG263 ValueSet | active | cic | 2025-02 | us | fhir | |
hl7.terminology | R5 | v3-RoleClassAffiliate | RoleClassAffiliate | active | 2014-03 | uv | tho | ||
hl7.fhir.cz.terminology | R5 | administrative-gender-cz | Gender for administrative purposes | active | 2022-12 | cz | fhir | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.7.1--20200901000000 | PolsRegelmatigheidCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.7.1--20171231000000 | PolsRegelmatigheidCodelijst | active | nl | sct | |||
hl7.fhir.cl.minsal.r2bo | R4 | r2bo-respuestas-infiltracion-perineural-vs | Set de Valores Para Hallazgos de Infiltración Perineural | informative | oo | 2025-08 | cl | sct | |
hl7.fhir.cl.minsal.r2bo | R4 | r2bo-respuestas-infiltracion-peritumoral-vs | Set de Valores Para Hallazgos de Infiltración Peritumoral | informative | oo | 2025-08 | cl | sct | |
hl7.fhir.cl.minsal.r2bo | R4 | r2bo-invasion-linfatica-VS | Set de Valores para Invasión Linfática y Vascular | informative | oo | 2025-08 | cl | sct | |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.2.1--20200901000000 | PositieCodelijst | active | nl | sct | |||
hl7.fhir.be.terminology | R4 | BeVSPopulationScreeningFollowUpAdvice | Population Screening Follow-up Advice Value Set | active | 1 | 2024-06 | be | sct | |
ch.fhir.ig.ch-lab-order | R4 | observation-triggeredby-type | Observation TriggeredBy Type | active | 2025-05 | ch | internal | ||
hl7.fhir.uv.extensions.r4b | R4B | artifactassessment-disposition | Artifact Assessment Disposition | trial-use | 1 | cds | 2020-12 | uv | fhir |
hl7.fhir.uv.extensions.r4b | R4B | artifactassessment-workflow-status | Artifact Assessment Workflow Status | trial-use | 1 | cds | 2020-12 | uv | fhir |
hl7.terminology | R5 | v3-SeverityObservation | SeverityObservation | active | 2014-03 | uv | tho | ||
ForgePatientChart.0830 | R4 | telus-identifier-system-practitioner-ln | TELUS ValueSet - Identifier System Practitioner LN | draft | 2021-03 | iso | |||
fhir.virtually.healthcare | R4 | PractitionerIdentifiers | Practitioner Identifiers | draft | 2025-08 | us | internal | ||
ForgePatientChart.0830 | R4 | telus-practitionerrole-code | TELUS ValueSet - PractitionerRole Code | draft | 2021-03 | tho | |||
hl7.fhir.uv.saner | R4 | PublicHealthMeasureAttachmentTypes | Public Health Measure Attachment Types | active | pher | 2024-05 | uv | ietf | |
hl7.terminology | R5 | allergyintolerance-clinical | AllergyIntolerance Clinical Status Codes | active | 3 | pc | 2024-04 | uv | tho |
hl7.terminology | R5 | condition-category | Condition Category Codes | active | 3 | pc | 2024-04 | uv | tho |
csiro.fhir.au.smartforms | R4 | condition-clinical | Condition Clinical Status Codes | trial-use | 3 | pc | 2019-10 | au | tho |
hl7.terminology | R5 | condition-clinical | Condition Clinical Status Codes | active | 3 | pc | 2024-04 | uv | tho |
signal.core.r4 | R4 | condition-severity | Condition/Diagnosis Severity | draft | pc | us | sct | ||
fhir.outburn.co.il | R4 | vs-jcpm-resource-category | Pregnancy & Delivery Profiles Clinical Category Codes | draft | us | ||||
hl7.fhir.be.pss | R4 | PregnancyCodes | Pregnancy Codes | active | 2025-07 | be | sct icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.84 | Other Pregnancy Outcome | active | 2024-06 | us | loinc | ||
uk.nhsdigital.r4.test | R4 | a95fa7c2-7732-4130-bf98-8dd09db81af3 | PrescribingPerformerSiteType | draft | |||||
HIE2.packages | R4 | results-laboratory-presence-absence-gps-uv-ips | Results Laboratory Presence/Absence (GPS) - IPS | active | 2022-01 | uv | sct | ||
hl7.fhir.cl.agenda | R4 | VSCategorias | VS Prestaciones | active | 2025-07 | cl | internal | ||
hl7.fhir.cl.agenda | R4 | VSPrestaciones | VS Prestaciones | active | 2025-07 | cl | internal | ||
fhir.cdc.opioid-cds-r4 | R4 | barbiturate-urine-drug-screening-tests | Barbiturate urine drug screening tests | draft | 2024-04 | us | |||
fhir.cdc.opioid-cds-r4 | R4 | benzodiazepine-urine-drug-screening-tests | Benzodiazepine urine drug screening tests | draft | 2024-04 | us | |||
fhir.cdc.opioid-cds-r4 | R4 | buprenorphine-urine-drug-screening-tests | Buprenorphine urine drug screening tests | draft | 2024-04 | us | |||
fhir.cdc.opioid-cds-r4 | R4 | heroin-urine-drug-screening-tests | Heroin urine drug screening tests | draft | 2024-04 | us | |||
fhir.cdc.opioid-cds-r4 | R4 | general-opiate-urine-drug-screening-tests | General opiate urine drug screening tests | active | 2023-05 | us | |||
fhir.cdc.opioid-cds-r4 | R4 | oxycodone-urine-drug-screening-tests | Oxycodone urine drug screening tests | draft | 2024-04 | us | |||
hl7.fhir.us.vdor | R4 | vdor-previous-overdose-timing-vs | VDOR Previous Overdose Timing | informative | pher | 2025-06 | us | fhir | |
hl7.fhir.us.vdor | R4 | vdor-previous-overdose-vs | VDOR Previous Overdose | informative | pher | 2025-06 | us | fhir | |
signal.core.r4 | R4 | questionnaire-ccars-previous-concurrent-services | Questionnaire CCARS Previous Concurrent Services | draft | 1 | pa | us | ||
hl7.fhir.cl.minsal.nid | R4 | VSPrevision | Previsión | active | 2023-01 | cl | internal | ||
hl7.fhir.cl.agenda | R4 | VSPrevision | VS Prevision | active | 2025-07 | cl | internal | ||
fhir.org.nz.ig.base | R4 | pho | PHO | active | 2025-06 | us | |||
ch.fhir.ig.ch-crl | R4 | nkrs-whocnsgradingsystem | NKRS - WHO(CNS) Grading System | active | 2022-02 | ch | sct | ||
hl7.terminology | R5 | v3-PrimaryDentition | PrimaryDentition | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1021.101 | Gender Identity USCDI core | active | 2024-02 | us | sct | ||
hl7.fhir.us.registry-protocols | R4 | PriorDiagnosticCoronaryAngiographyProcedureResults | Prior Diagnostic Coronary Angiography Procedure Results | active | cic | 2023-11 | us | fhir sct | |
hl7.fhir.uv.rfi-ig | R5 | rfi-priority | RFIPriority | draft | 2025-06 | uv | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1010.2 | Clinical Substance | active | 2024-06 | us | vsac | ||
hl7.terminology | R5 | v3-ActRelationshipEndsAfterOrConcurrentWithEndOf | ActRelationshipEndsAfterOrConcurrentWithEndOf | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipEndsAfterOrConcurrentWithStartOf | ActRelationshipEndsAfterOrConcurrentWithStartOf | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipEndsBeforeOrConcurrentWithEndOf | ActRelationshipEndsBeforeOrConcurrentWithEndOf | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipEndsBeforeOrConcurrentWithStartOf | ActRelationshipEndsBeforeOrConcurrentWithStartOf | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipEndsNearEnd | ActRelationshipEndsNearEnd | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipEndsNearStarts | ActRelationshipEndsNearStarts | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipStartsAfterOrConcurrentWithEndOf | ActRelationshipStartsAfterOrConcurrentWithEndOf | active | 2014-08 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipStartsAfterOrConcurrentWithStartOf | ActRelationshipStartsAfterOrConcurrentWithStartOf | active | 2014-08 | uv | tho |